Definitive Healthcare Corp. (DH) Spending and interest coverage
- R&D / revenue · 12 months: Value 13.22%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 10.88%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -21.88×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 13.22% | Research and development expense / revenue. Period ending 2026-06-30. $30.76M ÷ $232.70M × 100 ≈ 13.22% |
| Stock-based compensation / revenue · 12 months | 10.88% | Share-based compensation / revenue. Period ending 2026-06-30. $25.32M ÷ $232.70M × 100 ≈ 10.88% |
| Interest coverage · 12 months | -21.88× | Operating income ÷ reported interest expense. $-243.35M ÷ $11.12M ≈ -21.88× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 30.76M USD | Research and Development Expense |
| Revenue | 232.70M USD | |
| Stock-based compensation | 25.32M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -243.35M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 11.12M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.76M | $232.70M | $25.32M | $-243.35M | $11.12M | 13.22% | 10.88% | -21.88× | Reported |
| 2026-03-31 | $31.97M | $238.26M | $27.05M | $-240.78M | $11.48M | 13.42% | 11.35% | -20.97× | Reported |
| 2025-12-31 | $34.78M | $241.52M | $29.14M | $-224.27M | $11.29M | 14.40% | 12.07% | -19.87× | Reported |
| 2025-09-30 | $33.80M | $242.28M | $28.35M | $-297.21M | $11.93M | 13.95% | 11.70% | -24.91× | Reported |
| 2025-06-30 | $33.53M | $244.93M | $27.96M | $-513.89M | $12.68M | 13.69% | 11.42% | -40.52× | Reported |
| 2025-03-31 | $35.69M | $247.91M | $29.82M | $-879.36M | $13.45M | 14.39% | 12.03% | -65.36× | Reported |
| 2024-12-31 | $36.52M | $252.20M | $38.09M | $-710.82M | $14.84M | 14.48% | 15.10% | -47.91× | Reported |
| 2024-09-30 | $39.10M | $255.85M | $43.97M | $-621.34M | $15.23M | 15.28% | 17.19% | -40.80× | Reported |
| 2024-06-30 | $42.58M | $258.47M | $49.67M | $-691.35M | $15.38M | 16.47% | 19.22% | -44.97× | Reported |
| 2024-03-31 | $42.69M | $255.69M | $53.19M | $-333.78M | $15.40M | 16.70% | 20.80% | -21.67× | Reported |
| 2023-12-31 | $42.44M | $251.41M | $48.74M | $-329.80M | $15.20M | 16.88% | 19.39% | -21.69× | Reported |
| 2023-09-30 | $41.00M | $246.08M | $46.91M | $-330.26M | $11.93M | 16.66% | 19.06% | -27.69× | Reported |
| 2023-06-30 | $39.45M | $238.14M | $44.05M | $-44.94M | $11.11M | 16.56% | 18.50% | -4.05× | Reported |
| 2023-03-31 | $37.92M | $231.73M | $40.69M | $-42.11M | $10.07M | 16.37% | 17.56% | -4.18× | Reported |
| 2022-12-31 | $34.89M | $222.65M | $36.43M | $-41.26M | $8.41M | 15.67% | 16.36% | -4.90× | Reported |
| 2022-09-30 | $30.51M | $208.37M | $30.63M | $-43.80M | $8.85M | 14.64% | 14.70% | -4.95× | Reported |
| 2022-06-30 | $26.05M | $194.07M | $23.81M | $-38.40M | $13.56M | 13.42% | 12.27% | -2.83× | Reported |
| 2022-03-31 | $21.62M | $179.34M | $16.42M | $-33.81M | $19.30M | 12.06% | 9.16% | -1.75× | Reported |
| 2021-12-31 | $18.57M | $166.15M | $9.96M | $-24.98M | $25.87M | 11.17% | 5.99% | -0.97× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $11.06M | $118.32M | $1.75M | $-14.45M | $36.49M | 9.35% | 1.48% | -0.40× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-07-15 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOUNDHOUND AI, INC. (SOUN) | United States | $0.106B | |
| QUANTUM X LABS INC. (QXL) | $0.111B | ||
| Inspired Entertainment, Inc. (INSE) | United States | $0.121B | -23.10 |
| AUDIOEYE INC (AEYE) | United States | $0.089B | -15.97 |
| CareCloud, Inc. (CCLD) | United States | $0.088B | 11.27 |
| Rank One Computing Corp (ROC) | United States | $0.077B | |
| Fatpipe Inc/UT (FATN) | United States | $0.077B | |
| SOUNDTHINKING, INC. (SSTI) | United States | $0.072B | -7.19 |
| Great Elm Group, Inc. (GEG) | United States | $0.067B | -1.76 |
| Sports Entertainment Gaming Global Corp (SEGG) | United States | $0.066B | -0.25 |